Advertisement

Ocular Sarcoidosis

  • Padmamalini Mahendradas
  • Ankush Kawali
  • Sujay Chauhan
Chapter
Part of the Essentials in Ophthalmology book series (ESSENTIALS)

Abstract

Sarcoidosis is a multisystem granulomatous disease that presents a diagnostic challenge because of its varied clinical presentations. It is important to distinguish sarcoidosis from tuberculosis and other noninfectious posterior and panuveitis since the clinical manifestations of these entities are quite similar. Various imaging modalities can be used to diagnose and monitor the treatment response of sarcoidosis in the eye. This review article highlights the clinical features, diagnostic criteria, investigations, differential diagnosis and management options of sarcoidosis along with the roll of anterior segment and fundus photography, confocal microscopy, fundus autofluorescence, fundus fluorescein angiography including wide-field angiography, indocyanine green angiography, optical coherence tomography, and optical coherence tomography angiography in the diagnosis and management of eye manifestations of sarcoidosis.

Keywords

Sarcoidosis Fundus photography Fundus autofluorescence Fundus fluorescein angiography Indocyanine green angiography Optical coherence tomography Optical coherence tomography angiography 

Notes

Compliance with Ethical Requirements

Padmamalini Mahendradas, Anush Kawali, and Sujay Chauhan declare that they have no conflict of interest. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study. No animal studies were carried out by the authors for this chapter.

References

  1. 1.
    Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234–41.CrossRefGoogle Scholar
  2. 2.
    Newman LS, Rose CS, Bresnitz EA, et al. A case control etiological study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170:1324–30.CrossRefGoogle Scholar
  3. 3.
    Smith G, Brownell I, Sanchez M, et al. Advances in the genetics of sarcoidosis. Clin Genet. 2008;73:401–12.CrossRefGoogle Scholar
  4. 4.
    West SG. Sarcoidosis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 5th ed. Philadelphia: Elsevier Mosby; 2011. p. 1659–70.CrossRefGoogle Scholar
  5. 5.
    Agostini C, Adami F, Semenzato G. New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol. 2000;12:71–6.CrossRefGoogle Scholar
  6. 6.
    Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153–65.CrossRefGoogle Scholar
  7. 7.
    Lynch JP, Kazerooni EA 3rd, Gay SE. Pulmonary sarcoidosis. Clin Chest Med. 1997;18:755–85.CrossRefGoogle Scholar
  8. 8.
    Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G, Sharma OP. ATS/ERS/WASOG Statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:149–73.PubMedGoogle Scholar
  9. 9.
    James DG. Life-threatening situations in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1998;15:134–9.PubMedGoogle Scholar
  10. 10.
    ATS, ERS, WASOG. Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736–55.CrossRefGoogle Scholar
  11. 11.
    Sharma OP. Diagnosis of cardiac sarcoidosis: an imperfect science, a hesitant art. Chest. 2003;123:18–9.CrossRefGoogle Scholar
  12. 12.
    James DG, Sharma OP. Neurosarcoidosis. Proc R Soc Med. 1967;60:1169–70.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Stern BJ, Krumholz A, Johns C, et al. Sarcoidosis and its neurological manifestations. Arch Neurol. 1985;42:909–17.CrossRefGoogle Scholar
  14. 14.
    McMahon JF, Adam MK, Dunn JP. Optical coherence tomography and management of a retinal granuloma in presumed ocular sarcoidosis. Ocul Immunol Inflamm. 2018;10:1–5.CrossRefGoogle Scholar
  15. 15.
    Wachtel AS, Saunders M. Optic nerve sarcoidosis. Mayo Clin Proc. 1997;72:791.CrossRefGoogle Scholar
  16. 16.
    Gelwan MJ, Kellen RI, Burde RM, et al. Sarcoidosis of the anterior visual pathway: successes and failures. J Neurol Neurosurg Psychiatry. 1988;51:1473–80.CrossRefGoogle Scholar
  17. 17.
    Graham EM, Ellis CJ, Sanders MD, et al. Optic neuropathy in sarcoidosis. J Neurol Neurosurg Psychiatry. 1986;49:756–63.CrossRefGoogle Scholar
  18. 18.
    JSSOG. Diagnostic guidelines and criteria for sarcoidosis-2006 (Japan Society for sarcoidosis and other granulomatous disorders and Japanese Ocular Inflammation Society). J Jpn Ophthalmol Soc. 2007;111:118–21.Google Scholar
  19. 19.
    Herbort CP, Rao NA, Mochizuki M, Members of Scientific Committee of First International Workshop on Ocular Sarcoidosis. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17(3):160–9.CrossRefGoogle Scholar
  20. 20.
    Dave N, Chevour P, Mahendradas P, et al. Increased aqueous humor CD4+/CD8+ lymphocyte ratio in sarcoid uveitis. Ocul Immunol Inflamm. 2018;8:1–8.CrossRefGoogle Scholar
  21. 21.
    Kojima K, Maruyama K, Inaba T, et al. The CD4/CD8 ratioin vitreous fluid is of high diagnostic value in sarcoidosis. Ophthalmology. 2012;119:2386–92.CrossRefGoogle Scholar
  22. 22.
    Selroos O. Treatment of sarcoidosis. Sarcoidosis. 1994;11:80–3.PubMedGoogle Scholar
  23. 23.
    Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336:1224–34.CrossRefGoogle Scholar
  24. 24.
    Pietnalho A, Tukiainen P, Haahtela T, et al. Oral prednisone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double blind, placebo-controlled multicenter study. Finnish pulmonary sarcoidosis study group. Chest. 1999;116:424–31.CrossRefGoogle Scholar
  25. 25.
    Baughman RP, Lower EE. Steroid-sparing alternative treatments for sarcoidosis. Clin Chest Med. 1997;18:853–64.CrossRefGoogle Scholar
  26. 26.
    Gideon NM, Mannino DM. Sarcoidosis mortality in the United States 1979–1991: an analysis of multiple-cause mortality data. Am J Med. 1996;100:423–7.CrossRefGoogle Scholar
  27. 27.
    Moschos MM, Guex-Crosier Y. Anterior segment granuloma and optic nerve involvement as the presenting signs of systemic sarcoidosis. Clin Ophthalmol. 2008;2(4):951–3.. PubMed PMID: 19668451; PubMed Central PMCID:PMC2699804).CrossRefGoogle Scholar
  28. 28.
    Wertheim MS, Mathers WD, Planck SJ, et al. In vivo confocal microscopy of keratic precipitates. Arch Ophthalmol. 2004;122(12):1773–81.CrossRefGoogle Scholar
  29. 29.
    Kanavi MR, Soheilian M, Naghshgar N. Confocal scan of keratic precipitates in uveitic eyes of various etiologies. Cornea. 2010;29(6):650–4.CrossRefGoogle Scholar
  30. 30.
    Mahendradas P, Shetty R, Narayana KM, et al. In vivo confocal microscopyof keratic precipitates in infectious versus noninfectious uveitis. Ophthalmology. 2010;117(2):373–80.CrossRefGoogle Scholar
  31. 31.
    Tran VT, LeHoang P, Herbort CP. Value of high-frequency ultrasound biomicroscopy in uveitis. Eye (Lond). 2001;15(Pt 1):23–30.CrossRefGoogle Scholar
  32. 32.
    Yannuzzi LA, Ober MD, Slakter JS, et al. Ophthalmic fundus imaging: today and beyond. Am J Ophthalmol. Mar 2004;137(3):511–24.CrossRefGoogle Scholar
  33. 33.
    Feeney L. Lipofuscin and melanin of human retinal pigment epithelium. Fluorescence, enzyme cytochemical, and ultrastructural studies. Invest Ophthalmol Vis Sci. 1978;17(7):583–600.PubMedGoogle Scholar
  34. 34.
    Yeh S, Forooghian F, Wong WT, et al. Fundus autofluorescence imaging of the white dot syndromes. Arch Ophthalmol (Chicago, Ill: 1960). 2010;128(1):46–56.CrossRefGoogle Scholar
  35. 35.
    Haen SP, Spaide RF. Fundus autofluorescence in multifocal choroiditis and panuveitis. Am J Ophthalmol. 2008;145(5):847–53.CrossRefGoogle Scholar
  36. 36.
    Gupta A, Bansal R, Gupta V, Sharma A. Fundus autofluorescence in serpiginouslike choroiditis. Retina (Philadelphia, Pa). 2012;32(4):814–25.CrossRefGoogle Scholar
  37. 37.
    Rostaqui O, Querques G, Haymann P, et al. Visualization of sarcoid choroidal granuloma by enhanced depth imaging optical coherence tomography. Ocul Immunol Inflamm. 2014;22(3):239–41.CrossRefGoogle Scholar
  38. 38.
    Herbort CP. Fluorescein and indocyanine green angiography for uveitis. Middle East Afr J Ophthalmol. 2009;16(4):168–87.PubMedPubMedCentralGoogle Scholar
  39. 39.
    Herbort CP, LeHoang P, Guex-Crosier Y. Schematic interpretation of indocyanine green angiography in posterior uveitis using a standard angiographic protocol. Ophthalmology. 1998;105(3):432–40.CrossRefGoogle Scholar
  40. 40.
    Wolfensberger TJ, Herbort CP. Indocyanine green angiographic features in ocular sarcoidosis. Ophthalmology. 1999;106(2):285–9.CrossRefGoogle Scholar
  41. 41.
    Takahashi A, Nagaoka T, Yoshida A. Enhanced vitreous imaging optical coherence tomography in primary macular holes. Int Ophthalmol. 2016;36(3):355–63.CrossRefGoogle Scholar
  42. 42.
    Pang CE, Freund K, Engelbert M. Enhanced vitreous imaging technique with spectral-domain optical coherence tomography for evaluation of posterior vitreous detachment. JAMA Ophthalmol. 2014;132(9):1148–50.CrossRefGoogle Scholar
  43. 43.
    Goldberg NR, Jabs DA, Busingye J. Optical coherence tomography imaging of presumed sarcoid retinal and optic nerve nodules. Ocul Immunol Inflamm. 2015;24:1–4.Google Scholar
  44. 44.
    Baltmr A, Lightman S, Tomkins-Netzer O. Examining the choroid in ocular inflammation: a focus on enhanced depth imaging. J Ophthalmol. 2014;2014:459136.CrossRefGoogle Scholar
  45. 45.
    Invernizzi A, Mapelli C, Viola F, et al. Choroidal granulomas visualized by enhanced depth imaging optical coherence tomography. Retina. 2015;35(3):525–31.CrossRefGoogle Scholar
  46. 46.
    Mehta H, Sim DA, Keane PA, et al. Structural changes of the choroid in sarcoid and tuberculosis-related granulomatous uveitis. Eye (Lond). 2015;29(8):1060–8.CrossRefGoogle Scholar
  47. 47.
    Modi YS, Epstein A, Bhaleeya S, et al. Multimodal imaging ofsarcoid choroidal granulomas. J Ophthalmic Inflamm Infect. 2013;3(1):58.CrossRefGoogle Scholar
  48. 48.
    Pérez-Campagne E, Guex-Crosier Y, Schalenbourg A, et al. Giant nodular posterior scleritis compatible with ocular sarcoidosis simulating choroidal melanoma. Arch Soc Esp Oftalmol. 2007;82(9):563–6.CrossRefGoogle Scholar
  49. 49.
    Hirukawa K, Keino H, Watanabe T, Okada AA. Enhanced depth imaging optical coherence tomography of the choroid in new-onset acute posterior scleritis. Graefes Arch Clin Exp Ophthalmol. 2013;251(9):2273–5.CrossRefGoogle Scholar
  50. 50.
    Taki W, Keino H, Watanabe T, Okada AA. Enhanced depth imaging optical coherence tomography of the choroid in recurrent unilateral posterior scleritis. Graefes Arch Clin Exp Ophthalmol. 2013;251(3):1003–4.CrossRefGoogle Scholar
  51. 51.
    Papavasileiou E, Miller JB, Sobrin L. Swept-source optical coherence tomography findings in convalescent phase of treated sarcoid choroidal granulomas. Retin Cases Brief Rep. 2016;10(1):32–6.CrossRefGoogle Scholar
  52. 52.
    Sandhu R, Jia Y, Liang L, et al. Assessment of macular circulation in patients with retinal vasculitis using OCT angiography. Invest Ophthalmol Vis Sci. 2015;56:3359.Google Scholar
  53. 53.
    Sandhu R, Jia Y, Liu L, et al. Assessment of macular circulation in patients with retinal vasculitis using OCT angiography. Invest Ophthalmol Vis Sci. 2015;56:3359.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Padmamalini Mahendradas
    • 1
  • Ankush Kawali
    • 1
  • Sujay Chauhan
    • 1
  1. 1.Narayana Nethralaya, Department of Uveitis and Ocular ImmunologyBangaloreIndia

Personalised recommendations